Keywords: Mylan, Novartis, Lescol, ANDA, USA, Impax, Gralise, Depomed, Lipid lowerer, Post-herpetic neuralgia

Mylan debuts Lescol copy; Impax challenges Gralise patent

Article | 16 April 2012

Print This

US generic drug major Mylan (Nasdaq: MYL) revealed last Friday that it has begun shipping its generic version of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in